🇺🇸 FDA
Patent

US 11382929

Compositions and methods to treat disease

granted A61KA61K31/704A61K31/727

Quick answer

US patent 11382929 (Compositions and methods to treat disease) held by Regents of the University of Minnesota expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/704, A61K31/727, A61K31/785, A61P